Clinical Trial Update: Extension Study for Patients Entered Into Study Infacort 003 [Phase 3]

View source ↗

Summary

Extension study update for patients enrolled in Infacort 003 (Phase 3) completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Insufficiency

Drugs mentioned

• Infacort

Snippet

Sponsor: Neurocrine UK Limited | Conditions: Adrenal Insufficiency | Phase 3 | Status: COMPLETED | Results posted: 2019-09-13